Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia.
Mensink
H J
HJ
Department of Urology, Academic Hospital Groningen, The Netherlands.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use; D014563:Urodynamics / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C047638:alfuzosin